ESLA
Estrella Immunopharma, Inc.Company with tickers: ESLA, ESLAW
CIK
1844417
CUSIP
297584104
Shares Outstanding
43,034,228
Website
https://www.estrellabio.com
Investor Relations
https://www.estrellabio.com/investors
13F Activity (30d)
1 filings
1 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| DEF 14A | 2026-05-27 | 2026-06-29 | |
| 10-Q | 2026-05-18 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 10-K | 2026-03-18 | 2025-12-31 | |
| 8-K | 2026-01-13 | 2026-01-07 | |
| 8-K | 2026-01-06 | 2026-01-05 | |
| 8-K | 2025-12-04 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-06 | 2025-11-03 | |
| 8-K | 2025-09-29 | 2025-09-23 | |
| 8-K | 2025-09-26 | 2025-09-22 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-07 | 2025-08-01 | |
| 8-K | 2025-06-05 | — | |
| 8-K | 2025-06-03 | 2025-05-30 | |
| 8-K | 2025-05-29 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-02 | 2025-04-30 | |
| 8-K | 2025-02-21 | — | |
| 8-K | 2025-02-20 | 2025-02-19 | |
| 8-K | 2024-12-16 | — | |
| 8-K | 2024-12-06 | 2024-12-04 | |
| 8-K | 2024-11-26 | 2024-11-25 | |
| 8-K | 2024-11-25 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-07 | 2024-11-01 | |
| 8-K/A | 2024-11-07 | 2024-08-14 | |
| 10-K/A | 2024-10-28 | 2024-06-30 | |
| 10-K | 2024-09-27 | 2024-06-30 | |
| 8-K | 2024-08-20 | 2024-08-14 | |
| 8-K | 2024-08-06 | 2024-07-31 | |
| 8-K | 2024-07-02 | 2024-06-26 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-04-10 | — | |
| 8-K | 2024-03-11 | 2024-03-08 | |
| 8-K | 2024-03-07 | 2024-03-04 | |
| 10-Q | 2024-02-14 | 2023-12-31 | |
| 8-K | 2024-02-02 | 2024-01-30 | |
| 8-K | 2024-01-30 | — | |
| 10-Q | 2023-11-20 | 2023-09-30 | |
| 8-K/A | 2023-11-14 | 2023-09-29 | |
| 8-K | 2023-10-05 | 2023-09-29 | |
| 8-K | 2023-09-20 | 2023-09-14 | |
| 8-K | 2023-09-18 | — | |
| 8-K | 2023-08-18 | — | |
| 8-K | 2023-08-01 | 2023-07-31 | |
| 10-Q | 2023-08-01 | 2023-06-30 | |
| 8-K | 2023-07-26 | 2023-07-25 | |
| 8-K | 2023-07-21 | 2023-07-20 |
Showing 1–50 of 83 filings